Deleterious Mutation

general

Centers

Active Trials

$4.4B

Cancer Funding

Specific Cancer Types(6)

Name	Centers	Active Trials
Deleterious PALB2 Gene Mutation	9	11
Deleterious EPCAM Gene Mutation	7	7
Deleterious MLH1 Gene Mutation	7	7
Deleterious MSH2 Gene Mutation	7	7
Deleterious MSH6 Gene Mutation	7	7
Deleterious PMS2 Gene Mutation	7	7

Top Centers for Deleterious Mutation(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center	High-Volume Research Center	—	$2M	83.8
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	—	$1M	66.2
3	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		6	$911M	—
4	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive		7	$827M	—
5	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		1	$754M	—
6	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		6	$604M	—
7	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		6	$534M	—
8	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		1	$509M	—
9	University of Illinois Cancer CenterChicago, IL		6	$122M	—
10	Boston University Cancer CenterBoston, MA		7	$98M	—
11	Cancer Center at IllinoisUrbana, IL		6	$81M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →